Injeq Oy Shares Have Been Transferred to Finnish Book-Entry Securities System – Instructions for Shareholders

Injeq Oy Annual General Meeting resolved on 26th May 2021 to transfer the shares of the company into the Finnish book-entry securities system. Appropriate instructions were sent to all shareholders by email in June 2021 and on 16th September 2021 the shares were incorporated in the book-entry system. In case you have not received the said instructions, or your shares have not been transferred for some other reason, we ask you to contact ir@injeq.com for instructions.

The transfer to the Finnish book-entry securities system means that the maintenance of the Company’s shareholder register has been transferred to Euroclear Finland Ltd. A shareholder may not use shareholder rights in the Company before the shareholder has been registered in the shareholders’ register maintained in Euroclear Finland Ltd. The shareholding of each shareholder will be entered into the shareholder’s personal book-entry account in connection with the transfer to the Finnish book-entry securities system.

If your place of residence is outside Finland and your foreign bank can’t take into custody unlisted Finnish securities, and you are unwilling or unable to open a book-entry account in Finland, you do not need to do anything at this point – your ownership will remain unchanged. If the Company’s securities are listed in the future, this should allow your bank to then take custody of your newly listed securities.

For any questions or to update your contact information for future use please do not hesitate to contact us at ir@injeq.com.

Board of Directors of Injeq Oy

Injeq is one of the Europe’s Top 5 Medical Device Companies to Watch in 2023

Healthcare advancements that were mere ideas decades ago are coming to fruition, proving to be much more valuable to saving […]
Read more »

The 3rd part of Sievänen’s trilogy about traumatic lumbar punctures is out now: Incidence of traumatic lumbar punctures in adults: the impact of a patient’s first procedure

We are happy to announce that the last part of Sievänen’s traumatic lumbar punctures’ trilogy is now published. Two factors […]
Read more »

Päivi Lehtonen starting as Injeq’s new Sales Director in April

The current CEO of Teivo, Päivi Lehtonen, will start as Injeq’s new Sales Director in the beginning of April. Päivi […]
Read more »

We are excited to join the biggest German neurology event Neurowoche 2022

We are excited to join the biggest annual German neurology event Neurowoche 2022 with our distributor Ecumed. The congress takes […]
Read more »

Injeq participating Italian Neonatology congress SIN

Injeq is happy to join our Italian distributor Euromed at SIN – XXVIII Italian Neonatology Congress in beautiful Firenze. Come […]
Read more »

Injeq participating SIOP 2022 in Barcelona 28th September -1st October

Injeq is very excited to attend the SIOP Congress to present our amazing IQ-Tip system to doctors, patients and their […]
Read more »